Attached files
| file | filename |
|---|---|
| S-1/A - AMENDMENT NO.1 TO FORM S-1 - ROCKET PHARMACEUTICALS, INC. | d15839ds1a.htm |
| EX-1.1 - EX-1.1 - ROCKET PHARMACEUTICALS, INC. | d15839dex11.htm |
| EX-5.1 - EX-5.1 - ROCKET PHARMACEUTICALS, INC. | d15839dex51.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in this Amendment No. 1 to the Registration Statement (No. 333-206027) on Form S-1 of Inotek Pharmaceuticals Corporation of our report dated March 31, 2015, relating to our audit of the financial statements, which appear in the Annual Report on Form 10-K for the year ended December 31, 2014.
We also consent to the reference to our firm under the caption “Experts” in the Prospectus, which is part of this Registration Statement.
/s/ McGladrey LLP
Boston, Massachusetts
August 10, 2015